OLIG2 and medulloblastoma: Certainly, we observed that treatment with CT-179 decreased Olig2 phosphorylation in a mouse model of medulloblastoma (Dismuke et al., 2021) which may enable p53-mediated apoptosis (Mehta et al., 2011; Sun et al., 2011) and improve outcomes.